248 related articles for article (PubMed ID: 22341788)
21. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents.
Dar BA; Lone AM; Shah WA; Qurishi MA
Eur J Med Chem; 2016 Mar; 111():26-32. PubMed ID: 26854375
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antimicrobial and anticancer evaluation of N'-(substituted benzylidene)-2-(benzo[d]oxazol-3(2H)-yl)acetohydrazide derivatives.
Rohilla P; Deep A; Kamra M; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Lim SM
Drug Res (Stuttg); 2014 Oct; 64(10):505-9. PubMed ID: 24992500
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of chiral hydroxylated enones as potential anti-tumor agents.
Shing TK; Wu HT; Kwok HF; Lau CB
Bioorg Med Chem Lett; 2012 Dec; 22(24):7562-5. PubMed ID: 23102892
[TBL] [Abstract][Full Text] [Related]
24. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones.
Dimmock JR; Kandepu NM; Nazarali AJ; Kowalchuk TP; Motaganahalli N; Quail JW; Mykytiuk PA; Audette GF; Prasad L; Perjési P; Allen TM; Santos CL; Szydlowski J; De Clercq E; Balzarini J
J Med Chem; 1999 Apr; 42(8):1358-66. PubMed ID: 10212121
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
27. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
[TBL] [Abstract][Full Text] [Related]
28. Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents.
Sashidhara KV; Rosaiah JN; Kumar M; Gara RK; Nayak LV; Srivastava K; Bid HK; Konwar R
Bioorg Med Chem Lett; 2010 Dec; 20(23):7127-31. PubMed ID: 20951035
[TBL] [Abstract][Full Text] [Related]
29. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.
Zuliani V; Carmi C; Rivara M; Fantini M; Lodola A; Vacondio F; Bordi F; Plazzi PV; Cavazzoni A; Galetti M; Alfieri RR; Petronini PG; Mor M
Eur J Med Chem; 2009 Sep; 44(9):3471-9. PubMed ID: 19268405
[TBL] [Abstract][Full Text] [Related]
30. Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dione.
Romagnoli R; Baraldi PG; Salvador MK; Camacho ME; Balzarini J; Bermejo J; Estévez F
Eur J Med Chem; 2013 May; 63():544-57. PubMed ID: 23537942
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative activity and QSAR studies of a series of new 4-aminomethylidene derivatives of some pyrazol-5-ones.
Marković V; Erić S; Stanojković T; Gligorijević N; Aranđelović S; Todorović N; Trifunović S; Manojlović N; Jelić R; Joksović MD
Bioorg Med Chem Lett; 2011 Aug; 21(15):4416-21. PubMed ID: 21733686
[TBL] [Abstract][Full Text] [Related]
32. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1.
Yuan Q; Liu Z; Xiong C; Wu L; Wang J; Ruan J
Bioorg Med Chem Lett; 2011 Jun; 21(11):3427-30. PubMed ID: 21515048
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.
Serra S; Chicca A; Delogu G; Vázquez-Rodríguez S; Santana L; Uriarte E; Casu L; Gertsch J
Bioorg Med Chem Lett; 2012 Sep; 22(18):5791-4. PubMed ID: 22901895
[TBL] [Abstract][Full Text] [Related]
35. 4-Carbonyl-2,6-dibenzylidenecyclohexanone derivatives as small molecule inhibitors of STAT3 signaling pathway.
Ji P; Yuan C; Ma S; Fan J; Fu W; Qiao C
Bioorg Med Chem; 2016 Dec; 24(23):6174-6182. PubMed ID: 27816267
[TBL] [Abstract][Full Text] [Related]
36. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine.
Bielawski K; Bielawska A; Poplawska B
Arch Pharm (Weinheim); 2009 Aug; 342(8):484-90. PubMed ID: 19565602
[TBL] [Abstract][Full Text] [Related]
38. Bivalent bendamustine and melphalan derivatives as anticancer agents.
Scutaru AM; Wenzel M; Gust R
Eur J Med Chem; 2011 May; 46(5):1604-15. PubMed ID: 21371790
[TBL] [Abstract][Full Text] [Related]
39. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
Dullin A; Dufrasne F; Gelbcke M; Gust R
Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
[TBL] [Abstract][Full Text] [Related]
40. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
